manidipine has been researched along with Complications of Diabetes Mellitus in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study demonstrated that the combination of manidipine and delapril is as effective as losartan and hydrochlorothiazide in treatment of hypertension in type 2 diabetes." | 9.13 | Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes. ( Fogari, R; Kohlmann, O; Laurent, S; Roca-Cusachs, A; Schmieder, RE; Triposkiadis, F; Wenzel, RR, 2008) |
| "The effects of manidipine (10 mg/day for 7 days) on the renal hemodynamics and vasoactive humoral factors were examined in 6 adults with diabetes mellitus (DM)." | 9.07 | Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus. ( Fujishima, M; Fujita, S; Hirakata, H; Iino, K; Ishida, I; Kashiwagi, M; Okuda, S; Yoshinari, M, 1992) |
| "Manidipine has shown antihypertensive efficacy and appears to be well tolerated in adult and elderly patients with mild or moderate essential hypertension." | 8.81 | Manidipine: a review of its use in hypertension. ( Cheer, SM; McClellan, K, 2001) |
| "Manidipine 10 mg/day was added, increasing to 20 mg/day if the target BP was not reached after 3 months' treatment." | 6.76 | Manidipine for hypertension not controlled by dual therapy in patients with diabetes mellitus: a non-comparative, open-label study. ( de la Cruz, JJ; Martell-Claros, N, 2011) |
| "The study demonstrated that the combination of manidipine and delapril is as effective as losartan and hydrochlorothiazide in treatment of hypertension in type 2 diabetes." | 5.13 | Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes. ( Fogari, R; Kohlmann, O; Laurent, S; Roca-Cusachs, A; Schmieder, RE; Triposkiadis, F; Wenzel, RR, 2008) |
| "The effects of manidipine (10 mg/day for 7 days) on the renal hemodynamics and vasoactive humoral factors were examined in 6 adults with diabetes mellitus (DM)." | 5.07 | Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus. ( Fujishima, M; Fujita, S; Hirakata, H; Iino, K; Ishida, I; Kashiwagi, M; Okuda, S; Yoshinari, M, 1992) |
| "Manidipine has shown antihypertensive efficacy and appears to be well tolerated in adult and elderly patients with mild or moderate essential hypertension." | 4.81 | Manidipine: a review of its use in hypertension. ( Cheer, SM; McClellan, K, 2001) |
| "Manidipine 10 mg/day was added, increasing to 20 mg/day if the target BP was not reached after 3 months' treatment." | 2.76 | Manidipine for hypertension not controlled by dual therapy in patients with diabetes mellitus: a non-comparative, open-label study. ( de la Cruz, JJ; Martell-Claros, N, 2011) |
| "Manidipine is a third-generation dihydropyridine (DHP) calcium channel antagonist that blocks both L and T-type calcium channels." | 2.43 | Renal protection in hypertensive patients: selection of antihypertensive therapy. ( Wenzel, RR, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martell-Claros, N | 1 |
| de la Cruz, JJ | 1 |
| Fogari, R | 3 |
| Mugellini, A | 2 |
| Circelli, M | 1 |
| Cremonesi, G | 1 |
| Wenzel, RR | 2 |
| Roca-Cusachs, A | 1 |
| Schmieder, RE | 1 |
| Triposkiadis, F | 1 |
| Laurent, S | 1 |
| Kohlmann, O | 1 |
| Derosa, G | 1 |
| Zoppi, A | 1 |
| Rinaldi, A | 1 |
| Preti, P | 1 |
| Lazzari, P | 1 |
| Cheer, SM | 1 |
| McClellan, K | 1 |
| Hirakata, H | 1 |
| Iino, K | 1 |
| Ishida, I | 1 |
| Kashiwagi, M | 1 |
| Yoshinari, M | 1 |
| Okuda, S | 1 |
| Fujita, S | 1 |
| Fujishima, M | 1 |
3 reviews available for manidipine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diabetes Comp | 2011 |
Renal protection in hypertensive patients: selection of antihypertensive therapy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive | 2005 |
Manidipine: a review of its use in hypertension.
Topics: Aged; Animals; Antihypertensive Agents; Diabetes Complications; Dihydropyridines; Hemodynamics; Huma | 2001 |
4 trials available for manidipine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Manidipine for hypertension not controlled by dual therapy in patients with diabetes mellitus: a non-comparative, open-label study.
Topics: Aged; Antihypertensive Agents; Diabetes Complications; Dihydropyridines; Drug Therapy, Combination; | 2011 |
Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Co | 2008 |
Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihyperte | 2008 |
Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Calcium Channel Blo | 1992 |